All Gavin Screaton articles
-
News
AI model can accelerate development of new antivirals
Researchers have shown that IBM’s AI Model, MoLFormer, can generate antiviral molecules for multiple target virus proteins, including SARS-CoV-2, that can accelerate the drug discovery process.